| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,366 |
22,795 |
$4.01M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
26,863 |
24,480 |
$3.64M |
| 90832 |
Psychotherapy, 30 minutes with patient |
24,962 |
17,361 |
$3.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,621 |
21,432 |
$2.21M |
| 90834 |
Psychotherapy, 45 minutes with patient |
9,787 |
7,025 |
$1.59M |
| 36415 |
Collection of venous blood by venipuncture |
46,087 |
38,780 |
$1.52M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,302 |
4,194 |
$1.35M |
| 90791 |
Psychiatric diagnostic evaluation |
6,796 |
5,599 |
$1.30M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,063 |
2,049 |
$1.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,879 |
8,433 |
$984K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,009 |
1,998 |
$956K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,635 |
3,558 |
$891K |
| 80053 |
Comprehensive metabolic panel |
36,807 |
33,097 |
$735K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
10,053 |
9,658 |
$725K |
| 88342 |
|
2,414 |
2,391 |
$715K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,748 |
2,699 |
$707K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,258 |
3,128 |
$632K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,920 |
2,348 |
$604K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,313 |
2,567 |
$580K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,738 |
4,573 |
$506K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,544 |
3,880 |
$476K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,215 |
3,159 |
$467K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,104 |
7,188 |
$460K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
416 |
416 |
$378K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,282 |
12,763 |
$330K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,110 |
12,948 |
$321K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,599 |
1,233 |
$319K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
21,759 |
15,083 |
$308K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,579 |
2,034 |
$295K |
| 12001 |
|
473 |
470 |
$278K |
| 59025 |
Fetal non-stress test |
1,899 |
1,418 |
$259K |
| 93017 |
|
940 |
927 |
$231K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
10,978 |
10,844 |
$231K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,838 |
4,774 |
$220K |
| 99233 |
Prolong inpt eval add15 m |
5,907 |
1,617 |
$215K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
718 |
708 |
$215K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,700 |
3,689 |
$207K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,510 |
1,505 |
$207K |
| 97162 |
|
1,190 |
1,180 |
$184K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
3,189 |
1,032 |
$172K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,400 |
5,382 |
$171K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,064 |
1,026 |
$164K |
| 97010 |
|
2,644 |
1,057 |
$155K |
| Q3014 |
Telehealth originating site facility fee |
3,609 |
3,114 |
$152K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,154 |
1,784 |
$118K |
| 76830 |
Ultrasound, transvaginal |
2,914 |
2,865 |
$116K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,672 |
1,505 |
$101K |
| 80061 |
Lipid panel |
14,908 |
14,820 |
$93K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
282 |
280 |
$92K |
| 97161 |
|
899 |
895 |
$91K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,059 |
1,048 |
$88K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,285 |
9,239 |
$88K |
| H0001 |
Alcohol and/or drug assessment |
619 |
489 |
$87K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,410 |
9,294 |
$75K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,968 |
1,936 |
$72K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,488 |
2,486 |
$72K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16,420 |
15,228 |
$71K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,729 |
1,672 |
$64K |
| H0038 |
Self-help/peer services, per 15 minutes |
1,150 |
833 |
$64K |
| 83880 |
|
2,177 |
2,008 |
$64K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
45,836 |
39,571 |
$62K |
| 90837 |
Psychotherapy, 53 minutes with patient |
474 |
316 |
$61K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,044 |
2,524 |
$55K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
243 |
241 |
$51K |
| 86850 |
|
2,451 |
2,384 |
$51K |
| 84439 |
|
6,443 |
6,373 |
$51K |
| 82607 |
|
3,962 |
3,936 |
$47K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,683 |
1,682 |
$46K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
770 |
769 |
$46K |
| 99223 |
Prolong inpt eval add15 m |
694 |
683 |
$45K |
| 12002 |
|
70 |
70 |
$44K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
456 |
135 |
$44K |
| 99460 |
|
717 |
717 |
$43K |
| 11721 |
|
168 |
166 |
$42K |
| 71046 |
Radiologic examination, chest; 2 views |
8,751 |
8,523 |
$42K |
| 82570 |
|
12,824 |
9,276 |
$41K |
| 86901 |
|
2,616 |
2,535 |
$41K |
| 84153 |
|
2,089 |
2,069 |
$40K |
| 87510 |
|
2,924 |
2,884 |
$39K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
377 |
214 |
$36K |
| 86900 |
|
2,607 |
2,529 |
$36K |
| 86701 |
|
3,758 |
3,733 |
$35K |
| 90715 |
|
1,287 |
1,286 |
$35K |
| 82728 |
|
2,707 |
2,650 |
$35K |
| 93225 |
|
473 |
472 |
$34K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
105 |
105 |
$34K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,034 |
1,015 |
$32K |
| 87077 |
|
5,402 |
5,223 |
$32K |
| 84702 |
|
4,167 |
3,182 |
$31K |
| 80076 |
|
3,080 |
2,891 |
$31K |
| 93320 |
|
38 |
38 |
$30K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,640 |
6,400 |
$30K |
| 86803 |
|
3,036 |
3,022 |
$30K |
| 83655 |
|
2,259 |
2,256 |
$30K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
277 |
273 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
883 |
850 |
$28K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
323 |
276 |
$28K |
| 82746 |
|
2,417 |
2,399 |
$28K |
| G0378 |
Hospital observation service, per hour |
3,254 |
1,212 |
$27K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,703 |
3,692 |
$27K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
13 |
13 |
$27K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
44 |
44 |
$27K |
| 93971 |
|
582 |
563 |
$27K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
852 |
832 |
$27K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,302 |
1,282 |
$26K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,056 |
992 |
$26K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
55 |
54 |
$25K |
| 87070 |
|
3,954 |
3,895 |
$25K |
| 87040 |
|
3,818 |
3,330 |
$24K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
80 |
80 |
$24K |
| 94060 |
|
386 |
381 |
$24K |
| 81001 |
|
15,715 |
14,765 |
$23K |
| 87186 |
|
5,123 |
4,947 |
$22K |
| 97014 |
|
1,055 |
451 |
$21K |
| 70486 |
|
449 |
442 |
$20K |
| 95811 |
|
31 |
31 |
$20K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
918 |
908 |
$19K |
| 87653 |
|
878 |
869 |
$19K |
| 88304 |
|
665 |
664 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
198 |
196 |
$18K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
27 |
27 |
$18K |
| 76801 |
|
387 |
371 |
$18K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
337 |
125 |
$18K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,054 |
1,051 |
$18K |
| 76536 |
|
905 |
899 |
$17K |
| 84403 |
|
652 |
644 |
$17K |
| 84146 |
|
1,112 |
1,085 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,327 |
12,271 |
$16K |
| 87425 |
|
1,938 |
1,888 |
$16K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
487 |
485 |
$15K |
| 73564 |
|
1,953 |
1,912 |
$15K |
| 73630 |
|
3,302 |
3,132 |
$15K |
| 99442 |
|
528 |
475 |
$14K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
161 |
120 |
$13K |
| 88307 |
|
12 |
12 |
$13K |
| 94726 |
|
463 |
458 |
$13K |
| 81003 |
|
17,356 |
13,242 |
$13K |
| 83540 |
|
2,693 |
2,646 |
$12K |
| 71250 |
|
152 |
151 |
$12K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
67 |
51 |
$12K |
| 83970 |
|
271 |
267 |
$12K |
| 88312 |
|
1,045 |
1,036 |
$12K |
| 85610 |
|
9,796 |
8,851 |
$12K |
| 85730 |
|
5,594 |
5,410 |
$12K |
| 87660 |
|
810 |
798 |
$11K |
| 83735 |
|
5,743 |
4,870 |
$11K |
| 85027 |
|
3,886 |
3,629 |
$11K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
57 |
57 |
$11K |
| 72110 |
|
697 |
690 |
$11K |
| 74018 |
|
2,314 |
2,251 |
$11K |
| 77065 |
Tomosynthesis, mammo |
179 |
169 |
$11K |
| 87420 |
|
523 |
509 |
$10K |
| 82803 |
|
636 |
556 |
$10K |
| 82043 |
|
1,994 |
1,983 |
$10K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
12 |
12 |
$10K |
| 86706 |
|
696 |
694 |
$10K |
| 87522 |
Neg quan hep c or qual rna |
195 |
190 |
$10K |
| 87480 |
|
811 |
799 |
$9K |
| 83550 |
|
2,068 |
2,038 |
$9K |
| 76642 |
|
506 |
504 |
$9K |
| 73030 |
|
1,813 |
1,762 |
$9K |
| 72100 |
|
1,416 |
1,402 |
$9K |
| 82784 |
|
725 |
721 |
$9K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
12 |
12 |
$8K |
| 81025 |
|
2,611 |
2,518 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
370 |
352 |
$8K |
| 80348 |
|
1,592 |
649 |
$8K |
| 71271 |
|
265 |
262 |
$8K |
| 86140 |
|
2,421 |
2,203 |
$8K |
| 76775 |
|
186 |
186 |
$8K |
| 73130 |
|
2,247 |
2,105 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
8,891 |
8,466 |
$7K |
| 73610 |
|
2,288 |
2,141 |
$7K |
| 85379 |
|
1,165 |
1,150 |
$7K |
| 94729 |
|
285 |
280 |
$7K |
| 12011 |
|
24 |
24 |
$7K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
515 |
515 |
$7K |
| 77066 |
Tomosynthesis, mammo |
139 |
137 |
$7K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
333 |
144 |
$6K |
| 73110 |
|
1,683 |
1,526 |
$6K |
| 84100 |
|
1,681 |
1,347 |
$6K |
| 84402 |
|
233 |
232 |
$6K |
| 86592 |
|
1,838 |
1,830 |
$6K |
| 54150 |
|
83 |
83 |
$6K |
| 83690 |
|
8,865 |
8,085 |
$5K |
| 92567 |
|
337 |
335 |
$5K |
| 86038 |
|
1,076 |
1,068 |
$5K |
| 72141 |
|
13 |
13 |
$5K |
| 82950 |
|
1,048 |
1,045 |
$5K |
| 76641 |
|
283 |
280 |
$5K |
| 85651 |
|
3,066 |
2,891 |
$5K |
| 29125 |
|
25 |
25 |
$5K |
| 86762 |
|
314 |
313 |
$5K |
| 86705 |
|
477 |
475 |
$5K |
| 99443 |
|
362 |
362 |
$5K |
| 87340 |
|
453 |
451 |
$5K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
313 |
311 |
$5K |
| 80349 |
|
894 |
493 |
$4K |
| 82977 |
|
839 |
726 |
$4K |
| 10060 |
|
14 |
14 |
$4K |
| 87205 |
|
1,995 |
1,958 |
$4K |
| 83001 |
|
201 |
201 |
$4K |
| 92557 |
|
112 |
112 |
$4K |
| 86480 |
|
75 |
75 |
$4K |
| 70496 |
|
12 |
12 |
$4K |
| 74178 |
|
36 |
36 |
$3K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
102 |
100 |
$3K |
| 76870 |
|
68 |
67 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
40 |
36 |
$3K |
| 80329 |
|
226 |
222 |
$3K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
96 |
43 |
$3K |
| 86003 |
|
41 |
41 |
$3K |
| 87427 |
|
257 |
149 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
40 |
40 |
$3K |
| 82150 |
|
1,635 |
1,581 |
$3K |
| 82951 |
|
370 |
351 |
$3K |
| 73502 |
|
562 |
548 |
$3K |
| 93226 |
|
38 |
38 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
44 |
27 |
$2K |
| 84156 |
|
784 |
740 |
$2K |
| 83525 |
|
229 |
227 |
$2K |
| 84481 |
|
284 |
281 |
$2K |
| 84466 |
|
195 |
192 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
38 |
38 |
$2K |
| 84484 |
|
7,966 |
6,921 |
$2K |
| 83615 |
|
569 |
468 |
$2K |
| 86709 |
|
209 |
206 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
771 |
738 |
$2K |
| 86618 |
|
132 |
131 |
$2K |
| 84460 |
|
361 |
360 |
$2K |
| 99215 |
Prolong outpt/office vis |
17 |
12 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
67 |
67 |
$1K |
| 86364 |
|
212 |
206 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
29 |
28 |
$1K |
| 80324 |
|
274 |
177 |
$1K |
| 99219 |
|
16 |
16 |
$1K |
| 87328 |
|
121 |
118 |
$1K |
| 73562 |
|
401 |
385 |
$1K |
| 87329 |
|
122 |
119 |
$1K |
| 81329 |
|
14 |
14 |
$1K |
| 80353 |
|
276 |
186 |
$1K |
| 82550 |
|
1,133 |
1,026 |
$1K |
| 82105 |
|
208 |
207 |
$1K |
| 84703 |
|
2,013 |
1,957 |
$1K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
14 |
14 |
$1K |
| 86431 |
|
231 |
231 |
$1K |
| 80361 |
|
227 |
151 |
$1K |
| 73080 |
|
310 |
295 |
$1K |
| 87081 |
|
216 |
215 |
$1K |
| 97166 |
|
12 |
12 |
$1K |
| 82248 |
|
233 |
206 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,266 |
1,630 |
$1K |
| 87177 |
|
118 |
116 |
$1K |
| 80074 |
|
20 |
20 |
$964.33 |
| 84436 |
|
167 |
166 |
$963.20 |
| 87045 |
|
151 |
149 |
$888.35 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
275 |
120 |
$868.48 |
| 88142 |
|
38 |
38 |
$863.62 |
| 72040 |
|
102 |
102 |
$816.96 |
| 87015 |
|
264 |
261 |
$751.00 |
| 87449 |
|
2,779 |
1,414 |
$749.13 |
| 84450 |
|
157 |
157 |
$733.54 |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
15 |
14 |
$732.96 |
| 76813 |
|
24 |
24 |
$725.40 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,961 |
1,419 |
$721.30 |
| 87046 |
|
233 |
137 |
$702.10 |
| 93325 |
|
38 |
38 |
$668.91 |
| 82947 |
|
148 |
147 |
$655.50 |
| 92587 |
|
13 |
13 |
$600.00 |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
14 |
14 |
$598.24 |
| 73090 |
|
185 |
165 |
$594.72 |
| 72050 |
|
54 |
53 |
$580.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
585 |
557 |
$551.14 |
| 87209 |
|
80 |
80 |
$518.62 |
| 83605 |
|
3,377 |
3,123 |
$499.98 |
| 84550 |
|
139 |
136 |
$491.85 |
| 88112 |
|
15 |
15 |
$448.32 |
| 99462 |
|
14 |
14 |
$441.62 |
| S0028 |
Injection, famotidine, 20 mg |
979 |
855 |
$435.91 |
| 72070 |
|
53 |
53 |
$381.81 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,124 |
1,811 |
$359.20 |
| 87324 |
|
54 |
54 |
$358.82 |
| 86376 |
|
24 |
24 |
$349.20 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
336 |
327 |
$316.61 |
| 73590 |
|
99 |
96 |
$308.85 |
| 86141 |
|
54 |
54 |
$301.72 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,159 |
1,047 |
$290.00 |
| 73140 |
|
140 |
134 |
$270.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,904 |
9,088 |
$242.33 |
| 86308 |
|
279 |
278 |
$241.58 |
| 84144 |
|
12 |
12 |
$229.46 |
| 77062 |
|
13 |
13 |
$215.41 |
| 80320 |
|
709 |
653 |
$189.90 |
| 73521 |
|
27 |
27 |
$180.50 |
| 82785 |
|
12 |
12 |
$149.79 |
| 82274 |
|
71 |
69 |
$149.60 |
| 81015 |
|
229 |
224 |
$136.04 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,389 |
9,436 |
$123.72 |
| 80354 |
|
1,183 |
1,129 |
$117.76 |
| 86255 |
|
12 |
12 |
$114.40 |
| 86231 |
|
15 |
15 |
$109.80 |
| 84165 |
|
13 |
13 |
$104.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,022 |
1,913 |
$103.93 |
| 86787 |
|
12 |
12 |
$97.32 |
| 95806 |
|
107 |
107 |
$94.19 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,261 |
2,895 |
$87.99 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,822 |
1,787 |
$82.50 |
| 82962 |
|
2,685 |
1,866 |
$80.97 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,032 |
3,773 |
$78.55 |
| 82948 |
|
380 |
258 |
$76.51 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,662 |
2,378 |
$74.01 |
| 86735 |
|
12 |
12 |
$72.27 |
| 82465 |
|
12 |
12 |
$60.36 |
| 73100 |
|
13 |
13 |
$60.00 |
| 83721 |
|
12 |
12 |
$56.32 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,212 |
1,978 |
$53.61 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,924 |
4,820 |
$48.79 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,962 |
7,910 |
$46.76 |
| 82553 |
|
440 |
423 |
$40.25 |
| 81002 |
|
30 |
27 |
$34.04 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,268 |
2,638 |
$30.70 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
297 |
235 |
$26.25 |
| 82010 |
|
620 |
529 |
$15.31 |
| 73552 |
|
12 |
12 |
$11.74 |
| 83789 |
|
160 |
131 |
$10.75 |
| 71101 |
|
12 |
12 |
$10.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,179 |
3,111 |
$10.49 |
| J1815 |
Injection, insulin, per 5 units |
64 |
50 |
$9.96 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,662 |
3,577 |
$9.22 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
929 |
803 |
$7.86 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
1,992 |
1,930 |
$5.98 |
| 83986 |
|
159 |
130 |
$3.34 |
| J2060 |
Injection, lorazepam, 2 mg |
804 |
744 |
$2.14 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,053 |
1,733 |
$1.80 |
| 94760 |
|
447 |
436 |
$1.56 |
| J1630 |
Injection, haloperidol, up to 5 mg |
190 |
130 |
$1.38 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$0.12 |
| 87400 |
|
1,229 |
1,197 |
$0.00 |
| 00811 |
|
418 |
417 |
$0.00 |
| 00731 |
|
1,456 |
1,437 |
$0.00 |
| 90785 |
|
216 |
191 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,091 |
1,074 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
12 |
$0.00 |
| 00812 |
|
85 |
85 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
107 |
107 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
57 |
53 |
$0.00 |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
12 |
12 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
202 |
106 |
$0.00 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
14 |
14 |
$0.00 |
| 88313 |
|
12 |
12 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
120 |
90 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
13 |
13 |
$0.00 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
12 |
12 |
$0.00 |
| A4565 |
Slings |
24 |
24 |
$0.00 |
| A6234 |
Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
12 |
12 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,881 |
7,736 |
$0.00 |
| 01922 |
|
151 |
148 |
$0.00 |
| 96376 |
|
2,779 |
1,803 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
88 |
86 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,452 |
11,286 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
165 |
161 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
165 |
150 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
255 |
166 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
292 |
289 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
137 |
135 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
165 |
155 |
$0.00 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
119 |
119 |
$0.00 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
37 |
37 |
$0.00 |
| 97802 |
|
27 |
27 |
$0.00 |
| 73600 |
|
12 |
12 |
$0.00 |
| C1769 |
Guide wire |
13 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
12 |
12 |
$0.00 |